A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness ...

The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...

Digital therapeutics company Akili is planning to merge with Virtual Therapeutics. Upon closing, the combined organization would operate as privately held Virtual Therapeutics, with Akili as a wholly ...

Following its recent $30 million fundraise to advance its video game platform for neurological conditions such as attention deficit hyperactivity disorder and Alzheimer’s disease, Akili Interactive ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Promotional activity for Akili's ...

Boston, Massachusetts-based Akili Interactive Labs, which has developed a video game intervention for cognitive conditions, raised $30.5 million in a round led by PureTech Health with participation ...

Akili Interactive on Tuesday announced it will lay off 46% of its staff and evaluate strategic alternatives amid sluggish sales of its video game treatment for attention deficit hyperactivity disorder ...

The game is designed to improve attention span. After years of development and wading through regulatory processes, Boston’s Akili Interactive has received FDA permission for the first clinically ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...